Advertisement

Topics

| TREATMENT LIPSHINE

15:39 EDT 18th May 2013 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

ACTIVE INGREDIENT: TITANIUM DIOXIDE 7.0%

WARNING: STOP USE IF IRRITATION OCCURS

PRINCIPAL DISPLAY PANEL:

BOBBI BROWN

TREATMENT LIPSHINE SPF 15

NET WT/POIDS NET 0.7 OZ./2 g

BOBBI BROWN PROFESSIONAL COSMETICS INC.

NEW YORK, NY 10022

Manufacturer

BOBBI BROWN PROFESSIONAL COSMETICS INC

Active Ingredients

Source

Drugs and Medications [0 Results]

None

Clinical Trials [594 Associated Clinical Trials listed on BioPortfolio]

A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood After Dosing With Oral Inhalation From Dry Powder Inhalers

The purpose of this study is to investigate the time course of PF-00241939 concentrations in the blood following dosing by oral inhalation using dry powder inhalers.

Research on Individualized Treatment for Alcoholism

The purpose of this study was to compare the effects of two psychosocial treatments that differed in scope and intensity (Broad Spectrum Treatment and Motivational Enhancement Treatment) c...

Single Dose CHG Pharmacokinetic Study

A single 2% topical application of ReadyPrep® CHG was applied on either the abdomen (Treatment-1) or the groin (Treatment-2) whereas Treatment-3 consisted of a control treatment where the...

Preference and Vegetarian Diet in Weight Loss Treatment

We propose to add a treatment preference component to a larger study testing standard behavioral treatment (SBT) for weight loss without specific food group restriction vs standard behavio...

A Pharmacokinetics, Pharmacodynamics and Safety Study of Warfarin in Combination With Tamiflu (Oseltamivir)

This is an open-label, randomized, 2-period crossover study, to evaluate the pharmacokinetics, pharmacodynamics, safety and tolerability of warfarin in combination with Tamiflu (oseltamivi...

PubMed Articles [15509 Associated PubMed Articles listed on BioPortfolio]

Treatment consumption and treatment re-enrollment in GHB-dependent patients in The Netherlands.

The objective of this study was to assess treatment consumption and re-enrollment in treatment in patients with gamma-hydroxybutyrate (GHB)-dependence in Dutch Addiction Treatment Centers (ATCs) in co...

Exploring alternatives to reduce economical costs associated with FNA pre-treatment of waste activated sludge.

Recent studies have shown the effectiveness of Free Nitrous Acid (FNA) pre-treatment in enhancing sludge biodegradability and improving its methane production potential. FNA is regarded as an environm...

The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use.

Relatively little is known regarding the perception of medication-assisted treatments (MATs) and other treatment options amongst individuals that engage in non-medical prescription opioid use. This st...

Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.

Opioid Agonist Treatment (OAT) is the standard of care for the treatment of opioid use disorders. However, most people in treatment do not receive OAT. This study evaluated whether there are racial an...

The association between social capital and HIV treatment outcomes in South Africa.

HIV treatment has reduced morbidity and mortality. By 2012, it was estimated that 60.4% of eligible South Africans accessed antiretroviral treatment; however, treatment adherence and retention remain ...

Quick Search
Advertisement
 

Drugs and Medication Quicklinks


Searches Linking to this Drug Record